NL-OMON21473招募中不适用
actoferrin in the treatment of Long COVID
Stichting O&O Franciscus Gasthuis & Vlietland0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Persistent or newly developed long COVID symptoms at least 12 weeks post-primary SARS-CoV-2 infection
- •-Patients with a positive COVID-19 RT-PCR- or antibody test not older than 9 months
- •-Adult patients with age >18 years
排除标准
- •-Patients admitted to the ICU (COVID-19-related)
- •-COVID-19-related cardiac or pulmonary tissue damage
- •-Acute infection or current systemic immunological disorders
- •-Oral and/or inhaled use of corticosteroids or use of other immune-modulatory medication
- •-Current psychiatric disorders
- •-Communication difficulties
- •-Pregnant or lactating women
- •-Age >70 years
- •-Patients with milk allergy or a known or suspected allergy or any contraindications to lactoferrin or microcrystalline cellulose (lactoferrin can be used by individuals with lactose intolerance)
研究者
相似试验
已完成
不适用
actoferrin in the treatment of Long COVIDNL-OMON50577ongziekten72
Unknown
4 期
Antihistamines for treatment of Long COVIDCTRI/2022/07/043679Dr Arjun M C8
已完成
3 期
Effect of interfron in the treatment of covidCovid pneumonia.Coronavirus as the cause of diseaseB97.2IRCT20230930059562N1Imam hossein hospital80
暂停
2 期
Convalescent Antibody-Mediated Treatment of COVID-19 Infections in Patients with B-cell dysfunction, a Randomized Trial (COVID-Compromise Study).NL-OMON51203Academisch Medisch Centrum86
招募中
不适用
COVID-CompromiseNL-OMON25136AmsterdamUMC86